Q1 EPS Estimates for Henry Schein Cut by Zacks Research

Henry Schein, Inc. (NASDAQ:HSIC) – Analysts at Zacks Research cut their Q1 2026 EPS estimates for shares of Henry Schein in a research report issued on Thursday, October 17th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $1.41 for the quarter, down from their previous forecast of $1.42. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share.

HSIC has been the subject of a number of other reports. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research note on Friday, September 20th. JPMorgan Chase & Co. lowered their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Robert W. Baird dropped their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 7th. UBS Group reduced their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Finally, Evercore ISI increased their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein presently has an average rating of “Hold” and an average price target of $77.50.

Henry Schein Price Performance

HSIC opened at $72.39 on Monday. The company has a market capitalization of $9.27 billion, a price-to-earnings ratio of 24.46, a PEG ratio of 1.98 and a beta of 0.86. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. Henry Schein has a 12-month low of $60.01 and a 12-month high of $82.63. The business’s fifty day simple moving average is $70.40 and its 200-day simple moving average is $69.85.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. During the same period in the prior year, the firm earned $1.31 EPS. The company’s revenue for the quarter was up .0% compared to the same quarter last year.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Insiders own 1.14% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Everett Harris & Co. CA grew its holdings in shares of Henry Schein by 13.9% during the first quarter. Everett Harris & Co. CA now owns 119,257 shares of the company’s stock valued at $9,006,000 after buying an additional 14,580 shares during the last quarter. UniSuper Management Pty Ltd grew its stake in Henry Schein by 611.8% during the 1st quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company’s stock valued at $1,034,000 after purchasing an additional 11,771 shares during the last quarter. Envestnet Portfolio Solutions Inc. increased its holdings in shares of Henry Schein by 64.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock valued at $3,138,000 after purchasing an additional 16,241 shares during the period. Thompson Siegel & Walmsley LLC purchased a new position in shares of Henry Schein in the second quarter worth about $46,683,000. Finally, Nordea Investment Management AB lifted its holdings in shares of Henry Schein by 8.9% during the first quarter. Nordea Investment Management AB now owns 9,785 shares of the company’s stock worth $744,000 after purchasing an additional 798 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.